Skip to content

Comparison of topical esmolol and standard dressing in the treatment of diabetic foot ulcers

Comparison of efficacy of topical Esmolol versus conventional dressing in treatment of diabetic foot ulcers- A one year randomised controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108636
Enrollment
60
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Application of topical beta blocker over diabetic foot ulcers for 4weeks: Alternate day dressing with application of topical beta blocker over base of diabetic foot ulcers for 4 weeks C

Sponsors

Dr Sejal Mahajan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Type 1 or Type 2 diabetes undergoing therapy for glycaemic control 2. Ulcers lasting for at least 2 weeks with no improvement with good wound care and dressings 3. Subject is able and willing to comply with study procedures and adhere to protocol during the Study in the opinion of Investigator 4. A Subject agrees to sign informed consent form and allow audio visual recording of consent, if applicable

Exclusion criteria

Exclusion criteria: 1. Infected, gangrenous or ischemic ulcers with or without discharge or osteomyelitis 2. Subjects on ionotrope support, suffering from sinus bradycardia, A V block, right ventricular failure and cardiogenic shock 3. Subject has ulcers caused by a disease other than diabetes 4. Subjects allergic to the formulation

Design outcomes

Primary

MeasureTime frame
Reduction in ulcer areaTimepoint: 8 weeks

Secondary

MeasureTime frame
Change in ulcer areaTimepoint: 2weeks,4weeks,8weeks

Countries

India

Contacts

Public ContactDr Sejal Mahajan

Jawaharlal Nehru medical college , belagavi

anilbellad@gmail.com8660576419

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026